← 返回

NK 细胞的组织定位决定了对肺转移的监视

英文原题:Tissue localization of natural killer cells dictates surveillance of lung metastasis.

查看英文原题

Tissue localization of natural killer cells dictates surveillance of lung metastasis.

PubMed 2025/10/27(内容时间) Nat Commun Q1 · IF 18.1(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

肺是多种癌症类型的常见转移部位。对肺转移的成功免疫监视依赖于自然杀伤(NK)细胞,但其潜在机制尚不清楚。在此,我们发现肺血管系统通过整合素淋巴细胞功能相关抗原1(LFA-1)和极晚期抗原(VLA-4)招募并维持高细胞毒性、分化的CD11b高NK细胞。这些NK细胞迅速清除血管内转移的肿瘤细胞。然而,在初始清除阶段之后,分化的肺NK细胞大部分仍留在血管内,无法追踪已外渗的肿瘤细胞。相比之下,转移结节优先被循环中分化程度较低的CD27高NK细胞浸润。在转移肺内,CD11b高NK细胞的迁移和细胞毒性特征迅速受损,而结节内CD27高亚群则向转化生长因子β(TGF-β)驱动的状态转变,持久性有限。我们的研究结果表明,NK细胞的区室化是肺转移中有效肿瘤细胞监视的关键,并提示抗TGF-β的CD27高NK细胞可能为增强局部抗肿瘤活性提供有前景的治疗途径。

展开英文摘要原文

The lung is a common metastatic site for various cancer types. Successful immune surveillance of lung metastasis depends on Natural Killer (NK) cells, but the underlying mechanisms are elusive.

Here, we show that the pulmonary vasculature recruits and maintains highly cytotoxic, differentiated CD11b high NK cells through the integrins Lymphocyte Function-associated Antigen 1 (LFA-1) and Very Late Antigen (VLA-4). These NK cells rapidly eradicate metastasizing tumor cells within the vasculature.

However, after the initial clearing phase, differentiated pulmonary NK cells largely remain intravascular and fail to track extravasated tumor cells. In contrast, metastatic nodules are preferentially infiltrated with circulating, less differentiated CD27 high NK cells. Within the metastatic lung, CD11b high NK cells undergo a rapid impairment of their migratory and cytotoxic features, while the intranodular CD27 high subset transitions towards a transforming growth factor β (TGF-β)-driven state with limited persistence.

Our findings demonstrate that the compartmentalization of NK cells is key for effective tumor cell surveillance in lung metastasis and suggests that TGF-β-resistant CD27 high NK cells may offer a promising therapeutic avenue to enhance local anti-tumor activity.

论文信息

作者
Vermeer M、Sparano C、Coianiz N、Mayoux M、Litscher G、Fonseca A、Dergun S、Mussak C
第一作者单位
Innate Lymphoid Cells and Cancer, Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.Switzerland
通讯作者单位
Innate Lymphoid Cells and Cancer, Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland. tugues@immunology.uzh.ch.Switzerland
期刊
Nature communications2025 Oct 27
原文标识
PubMed 41145419 · DOI 10.1038/s41467-025-64531-7